# Cerebrospinal Fluid Biomarkers for Brain Tumors

> **NCT04692324** · — · RECRUITING · sponsor: **Mayo Clinic** · enrollment: 400 (estimated)

## Conditions studied

- Central Nervous System Neoplasm

## Interventions

- **PROCEDURE:** Biospecimen Collection
- **OTHER:** Electronic Health Record Review

## Key facts

- **NCT ID:** NCT04692324
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2021-01-14
- **Primary completion:** 2028-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2026-04-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04692324

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04692324, "Cerebrospinal Fluid Biomarkers for Brain Tumors". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04692324. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*